← Leaderboards
Robert Newman
University Of Tx Md Anderson Can Ctr
$500,935
Attributed
$500,935
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $363.4K · FY2009–11$500K$375K$250K$125K$0
'09
'10
'11
Funding mix
By agency
NIH$500,935 · 1
By mechanism
N01$500,935 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Joe H. Simmons$2,549,198
- William D Hopkins$17,983,314
- Sriram Yennu$3,268,567
- Gunapala Shetty$4,184,786
- Varsha Gandhi$2,500,715
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsEnzymesAnalytical MethodDrug FormulationsAnimal TissueDrug Or Chemical Tissue DistributionAnimalsBiological AvailabilityArea Under CurveDrug ExposureAutopsyCanis FamiliarisBiochemicalCell PreparationBiologicalComputing MethodologiesContinuous InfusionContractorContractsBiological ModelsDesignBody FluidsDoseGenomics
Grant awards (3)
Preclinical Pharmacology Studies of Antitumor & Other Therapeutic Agents$41,500
N01 · FY2011 · CA · contact PI
Preclinical Pharmacology Studies of Antitumor & Other Therapeutic Agents$96,000
N01 · FY2010 · CA · contact PI
Preclinical Pharmacology Studies of Antitumor & Other Therapeutic Agents$363,435
N01 · FY2009 · CA · contact PI